8.
[]. He Y, et al. Neuroprotective agent riluzole potentiates postsynaptic GABA(A) receptor function. Neuropharmacology. 2002 Feb;2(2):99-209.
[2]. Thompson JM, et al. Small-conductance calcium-activated potassium (SK) channels in the amygdala mediate pain-inhibiting effects of clinically available riluzole in a rat model of arthritis pain. Mol Pain. 205 Aug 28;:5.
[3]. Ali Ghaleiha, et al. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial. Paediatr Drugs. 203 Dec;5(6):505-.
[]. Daniel Kiblboeck, et al. A misguided 'pill in the pocket' approach with flecainide leading to cardiac arrest. BMJ Case Rep. 202 Aug 27:202:bcr202006868.
[5]. Denis Fourches, et al. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 200 Jan;23():7-83.
P26-P270-P330-P05-P50
6.
28
![]()
![]()